Citadel Advisors
OPTN

Citadel Advisors’s OptiNose OPTN Stock Holding History

Citadel Advisors’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-153
Closed -$4.44K – 14976
2023
Q1 		$4.44K Sell
153
-1,360
-90% -$36.2K ﹤0.01% 13957
2022
Q4 		$42K Buy
1,513
+653
+76% +$24.8K ﹤0.01% 12353
2022
Q3 		$47K Buy
+860
New +$47.2K ﹤0.01% 11680

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors's OPTN Position: Q3 2024 in Review

Citadel Advisors sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 2,603 shares — an estimated $40.6K sold.

Citadel Advisors first reported a position in OPTN in Q3 2018 and held it in 17 quarters. The position peaked at $1.22M in Q3 2018. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Citadel Advisors reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 2,603 OptiNose shares in Q3 2024, an estimated $40.6K.
  • Citadel Advisors first reported a position in OptiNose in Q3 2018 and held it in 17 quarters.
  • Citadel Advisors's OptiNose position peaked at $1.22M in Q3 2018.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.